Introduction
Pathological lesions caused by lipotrope-deficient diets, and the causative mechanisms have been the subject of much interest since the 1930s (1) (2) (3) (4) . Lipotropes include choline, methionine, folic acid and vitamin B 12 , all of which are basically involved in the generation of labile methyl groups. Among various types of different lipotrope-deficiencies, prolonged feeding of a combined choline-deficient, methioninelow (CDML*) diet is now established to cause hepatocellular carcinomas associated with fatty liver, hepatocyte injury, fibrosis and cirrhosis in rodents (1) (2) (3) . This thus provides an experimental hepatocarcinogenesis model caused by endogenous factors. Hypomethylation of DNA and RNA, repeating cycles of hepatocyte injury and regeneration, oxidative stress, chronic activation of protein kinase C, have been postulated to be involved (see references cited in 5). To allow precise assessment, L-amino acid-based, lipotrope-deficient diets have been developed to replace semisynthetic ones (2, 6, 7) , and we recently found that a choline-deficient (methionine-low), Lamino acid-defined (CDAA) diet, almost completely devoid of choline, possesses a greater capacity than a semisynthetic CDML diet to cause hepatocellular carcinomas, as well as oxidative DNA damage in rat liver (8, 9) .
There is now abundant evidence that a CDML diet causes a perturbation of the arachidonic acid (AA) cascade (10) (11) (12) (13) (14) (15) (16) . Inhibition of phosphatidylcholine synthesis by a CDML diet through either Kennedy or methylation pathways resulting in membrane depletion (1, 4) , which disturbs the formation of very low density lipoprotein (VLDL), and in turn causes accumulation of free fatty acids, particularly free AA, and 1,2-sn-diradylglycerol in the liver (10) (11) (12) . The depletion also appears to influence the membrane structure and function, altering the relative compositions of fatty acids in the microsomal and nuclear membranes, particularly those derived from AA (13) , while increasing phospholipase (PL) A 2 (13, 14) and C (14) activities. Moreover, it has been reported that activation of protein kinase C by 1,2-sn-diacylglycerol results in production of PGE 2 and/or PGF 2α in rat hepatocytes through activation of mitogen-activated protein kinase and cytosolic PLA 2 (15) . The accumulated free AA, derived from either the disturbed VLDL formation or the increased PLA 2 and PLC activities, can flow into the AA cascade. In fact, increased levels of prostaglandin (PG) E 2 in the livers of rats fed a CDML diet have been reported (16) . Recently, we have elucidated that an irreversible inhibitor of cyclooxygenase (COX), aspirin, can prevent hepatocarcinogenesis as well as fibrosis, cirrhosis and oxidative DNA damage, without affecting generation of a fatty liver, in rats given a CDAA diet (5, 17) . The PLA 2 inhibitor pbromophenacylbromide also exerts similar but less pronounced inhibitory influence, while the lipoxygenase (LOX) inhibitors quercetin and nordihydroguaiaretic acid demonstrate weak effects on hepatocarcinogenesis, without affecting the fatty liver, fibrosis, cirrhosis and oxidative DNA damage (5). Our findings suggest key roles of the COX pathway in causation of pathological lesions by a CDAA diet.
Nonsteroidal antiinflammatory drugs, now considered promising candidates for cancer chemopreventive agents (18, 19) , are basically inhibitors of COX which produces PGs, thromboxane (TX)s and prostacyclins from free AA (19, 20) . Their preventive potential might thus be due to the fact that PGs influence tumor growth, either by directly stimulating tumor cell proliferation (20) or by inhibiting immunological surveillance (20, 21) . Various tumor tissues including hepatoma cell lines are known to produce high levels of PGs (20) (21) (22) (23) , and recently, increased expression of COX-2 which is, in contrast to the constitutively expressed COX-1, inducible and postulated to be involved in inflammation and cell proliferation (24) , has been reported in colon, skin and mammary tumors (25) (26) (27) (28) as well as in V-Ha-ras-transformed mammary epithelial cells (28) . Further, overexpression of COX-2 in rat intestinal epithelial cells reportedly renders them resistant to apoptosis, which can be reversed by the COX inhibitor sulindac (29) . Suppression of intestinal polyposis in APC gene knockout mice by double knockout of the COX-2 gene has also been described (30) . Therefore, roles of perturbation of the COX pathway during hepatocarcinogenesis caused by a CDML diet, might thus provide clues for prevention.
In the present study, distinct chemical classes of COX inhibitors, exemplified by the long-acting piroxicam (PIRO) (enolic acid type), and the short-acting ibuprofen (IBU) (propionic acid type), and indomethacin (IND) (acetic acid type) (31), were therefore investigated for their effects on CDAAinduced lesions.
Materials and methods
Chemicals PIRO, IBU and IND were obtained from Sigma Chemical Co., St Louis, MO; and anti-glutathione S-transferase placental form (GST-P) polyclonal antibody from Medical and Biological Laboratories Co., Ltd., Nagoya, Japan. Authentic samples of 8-hydroxydeoxyguanosine (8-OHdG) were purchased from Wako Pure Chemical Industries Ltd., Osaka, Japan.
Animals, diets and drinking water
Fischer-344 male rats were obtained from Japan SLC Inc., Hamamatsu, Japan, and were 8 weeks of age, weighing 180-200 g, at the commencement of all experiments. CDAA (no. 518753) and choline-supplemented CSAA (no. 518754) diets were obtained from Dyets Inc., Bethlehem, PA. Details of the composition of the CDAA and CSAA diets have been described previously (8) . The lipotope contents of the CDAA diet were 1.75 g/kg methionine, 0 mg/kg (less than the detectable limit) of choline, 0.11 mmol/kg phosphatidylcholine, 10 µg/kg vitamin B 12 and 2 mg/kg folic acid. The CDAA and CSAA diets supplemented with PIRO, IBU and IND were stocked at 4°C in the dark, and given to the animals by freshly replenishing the diets once or twice a week. Drinking water containing IND was prepared twice a week by diluting a stock solution (10 mg/ml in 99.5% ethanol) with tap water. The diets and drinking water containing IND were administered in containers protected from light. Food and drinking water intake and body weights were measured weekly for the first 12 weeks and every other week thereafter.
Experimental protocols
In experiment A, animals were divided into 14 groups consisting of 6-14 rats each. Group 1 was fed the CDAA diet alone and groups 2, 3 and 4 the same diet supplemented with 0.01, 0.02 and 0.04% PIRO, respectively. Groups 5, 6 and 7 were given the CDAA diet supplemented with 0.02, 0.04 and 0.06% IBU, respectively. Groups 8, 9 and 10 received the CDAA diet alone and 1924 drinking water containing 0.001, 0.002 and 0.004% IND, respectively. Group 11 was fed the CSAA diet alone and groups 12 and 13 were given CSAA diet supplemented with 0.02% PIRO and 0.04% IBU, respectively. Group 14 was fed the CSAA diet alone and drinking water containing 0.002% IND. The diets and drinking water were available continuously, and the animals were killed 12 weeks after the commencement of the experiment except for half of these in groups 1, 3, 6, 9, 11, 12, 13 and 14 which were killed after 30 weeks. In experiment B, the effects of higher doses of PIRO and IBU were examined in four groups of animals consisting of 7-8 rats each. Group 1 was fed CDAA diet alone while groups 2-4 received the same diet supplemented with 0.04 and 0.06% PIRO, and 0.06% IBU, respectively. All the animals were killed 30 weeks after the commencement of the experiment. In experiment C, to examine the influence of higher doses of IND, animals were divided into five groups consisting of 10-12 rats each. Group 1 was fed CDAA diet alone and groups 2 and 3 the same diet supplemented with 0.005 and 0.008% IND, respectively. Group 4 was fed CSAA diet alone and group 5 the CSAA diet supplemented with 0.008% IND. Half of the animals in each group were killed after 12 weeks and the remainder after 30 weeks. The livers were analyzed for γ-glutamyltransferase (GGT)-or GST-P-positive preneoplastic foci and fibrosis at the 12 week time point, and for GST-Ppositive nodules, neoplastic nodules, hepatocellular carcinomas and cirrhosis at the 30 week time point. In addition, portions of the livers were frozen in liquid nitrogen and anlyzed for oxidative DNA damage (8-OHdG) at the 12 week time point.
Enzyme histochemical, immunohistochemical and histological studies
One slice from each liver lobe was taken for analysis at the 12 week time point while entire livers were step-sliced at 3 mm, using every other slice at the 30 week time point analysis. The tissues were fixed in acetone under dehydration by molecular sieves 3A1/8 (Wako Pure Chemical Industries Ltd., Osaka, Japan) at 0-4°C for 1-3 weeks except for in experiment C where 95% ethanol containing 1% acetic acid in ice for 2-3 h followed by 99.5% ethanol at 4°C overnight, was applied. Four serial sections were made from routinely prepared paraffin blocks, and were submitted to GGT, GST-P, hematoxylin and eosin (HE) and azan-Mallory stainings. GGT activity was demonstrated histochemically by the method of Rutenberg et al. (32) , and GST-P immunohistochemically by the avidin-biotin-peroxidase complex (ABC) method using a Vectastain Elite ABC kit, PK-6101 (Vector Laboratories, Burlingame, CA) as described previously (33) . The numbers and areas of GGT-and GST-P-positive foci and nodules were analyzed using a color image processor SPICCA II (Olympus Optical Corp., Tokyo, Japan) as detailed earlier (5). Neoplastic nodules and hepatocellular carcinomas were diagnosed histologically according to the criteria of Squire and Levitt (34) , and fibrosis and cirrhosis assessed by the degree of azan-Mallory staining.
Measurement of 8-OHdG levels
Liver DNA was extracted using a DNA Extractor WB Kit (Wako Pure Chemical Industries Ltd., Osaka, Japan), as described previously (5), denatured by heating at 95°C for 2 min and digested with nuclease P1 (Yamasa Corp., Chiba, Japan) and alkaline phosphatase from bovine intestinal mucosa (Type VII-S; Sigma) at 37°C for 1 h according to the method of Kasai (5). 8-OHdG was determined using a HPLC system basically comprising a Hitachi L-6000 pump (Hitachi Ltd., Tokyo, Japan), an Ultrasphere ODS column (4.6 ϫ 250 mm) (Beckman Instruments Inc., Fullerton, CA) and a Hitachi column oven 665A-52 (30°C), connected to a Hitachi UV detector L-4000 and an electrochemical detector Coulochem II (ESA Inc., Bedford, MA) eluating with 10 mM NaH 2 PO 4 solution containing 5% methanol, following established protocols (5) .
Statistical analysis
Quantitative differences between group values were statistically analyzed using ANOVA (analysis of variance), with multiple comparison Dunnett posttests, the Student's t-test, the chi-squared test, Fischer's exact test and z analysis.
Results

Twelve week time point
Body and liver weights, and food and drinking water intake data. Experimental data for rats in experiments A and C at the 12 week time point are summarized in Table I . None of the inhibitors PIRO, IBU and IND, significantly affected the final body weights or food and drinking water intake during this 12 week experimental period. Liver weights in groups 3 (CDAAϩ0.02% PIRO) and 4 (CDAAϩ0.04% PIRO) in experiment A were significantly increased in terms of both absolute values and ratios to body weights as compared with the CDAA alone group.
Data for GST-P-or GGT-positive liver foci. Data for numbers and sizes of GST-P-or GGT-positive foci in rats in experiments
A and C at the 12 week time point are summarized in Table II . PIRO at doses of 0.02 and 0.04% exerted a significant inhibitory effect on the development of GST-P-positive foci, with the foci number/cm 2 of the liver, the percent liver area occupied, and the average size all being significantly decreased as compared with the CDAA alone group. PIRO even at the dose of 0.01% exhibited a slight inhibitory effect on the foci development, significantly decreasing the proportion of the foci Ͼ0.2 mm 2 and tending to reduce the number, the per cent liver area and the average size. IBU only exerted a slight inhibitory effect on the development of GST-P-positive foci at the highest dose of 0.06%. IND did not significantly affect the development of either GST-P-or GGT-positive foci at any dose.
Histopathological findings. Histopathological findings for the livers in experiments A and C at the 12 week time point are summarized in Table II . The CDAA diet caused severe, diffuse fatty change, and diffuse fibrosis consisting of relatively thin fibers forming periportal-periportal (P-P), periportalcentrolobular (P-C) or C-C bridges with frequent nodule formation in experiment A (Figure 1a ), but with scarce nodule formation in experiment C. None of the inhibitors affected the induction of fatty liver. PIRO at the doses of 0.02 and 0.04%, dose-dependently decreased the incidence and grade of fibrosis (Figure 1b) . IBU, particularly at the highest dose, decreased the grade of fibrosis. IND at the doses of 0.002 and 0.004% in experiment A, slightly decreased the grade of fibrosis, while 0.005 and 0.008% IND in experiment C did not exhibit significant effects, although in this case the less prominent fibrosis in the CDAA alone group made differences difficult to assess.
Effects of the inhibitors on the induction of oxidative DNA damage.
Results for the effects of PIRO, IBU and IND on the generation of 8-OHdG in rats given a CDAA diet for 12 weeks are summarized in Table I . PIRO at the doses of 0.01, 0.02 Figure 2b and 2c, the livers of four out of seven rats (57.1%) in group 2 (CDAAϩ0.04% PIRO) and those of six out of seven rats (85.7%) in group 3 (CDAAϩ0.06% PIRO) in experiment B exhibited no cirrhotic features, with the entire surface being smooth. The livers of six out of eight rats (75.0%) in group 4 (CDAAϩ0.06% IBU) in experiment B exhibited slightly less prominent cirrhotic features, with the surfaces being patchily smooth, as shown in Figure 2d . Neither dose of IND in experiments A and C exhibited any obvious effects.
Numbers and sizes of GST-P-positive liver nodules.
Representative GST-P-positive nodules in rats given the CDAA diet alone for 30 weeks are shown in Figure 3a . A proportion of the numerous nodules filling the whole livers exhibited the GST-P-positive phenotype. Data for the numbers and sizes of GST-P-positive nodules in experiments A, B and C at 30 week time point are summarized in Table IV . PIRO at the doses of 0.04 and 0.06% dose-dependently inhibited the development of GST-P-positive nodules, with the nodule number/cm 2 of liver, the per cent liver area occupied and the average size all being significantly decreased as compared with the CDAA alone group values in experiment B. PIRO at the dose of 0.02% also significantly decreased the average size and the proportion of the nodules Ͼ2.0 mm 2 in experiment A. IBU only exerted a slight but significant inhibitory effect on the development of GST-P-positive nodules at the highest dose of 0.06%. In contrast, none of the doses of IND significantly affected the nodule development. Histopathological findings. Histopathological findings for the livers of rats in experiments A, B and C at the 30 week time point are summarized in Table IV . As shown in Figure 3c , the livers of rats given the CDAA diet alone for 30 weeks exhibited features of fatty cirrhosis, with entire livers being comprised of numerous and various sized regenerative nodules which were composed of hepatocytes with numerous large fat droplets and surrounded by relatively thin fibrotic septa. Some of the nodules exhibited a GST-P-positive phenotype, the majority of these being composed of hepatocytes with a lesser degree of fatty change. A small portion of the nodules were neoplastic nodules demonstrating cytoplasmic, nuclear, nucleolar and architectural atypia (Figure 3b ), some of these being negative for GST-P expression. Hepatocellular carcinomas were not observed in the present study. None of the inhibitors significantly affected the fatty change. PIRO at doses of 0.04 and 0.06% dose-dependently decreased the incidence and grade of liver cirrhosis as compared with the CDAA alone group (Figure  3d ), while IBU only at the highest dose 0.06% slightly decreased the grade, as evidenced by the lower numbers and smaller sizes of regenerative nodules and thinner fibrotic septa (Figure 3e ). In contrast, IND did not significantly affect the development of cirrhosis in experiments A or C.
Discussion
The present results, together with our previous reports (5, 17) , indicate that inhibitors of COX, like the irreversibly acting aspirin and long-acting PIRO, and to a much lesser extent the short-acting IBU, can inhibit fibrosis, cirrhosis, oxidative DNA damage and the associated development of preneoplastic and neoplastic liver lesions, caused by a CDAA diet in rats without any associated effects on fatty change. IND, another shortacting COX inhibitor, on the other hand, did not exhibit any clear, dose-dependent inhibitory effects. The present findings that not all COX inhibitors demonstrate preventive effects, might throw doubt upon our assumption of an involvement of the COX pathway in lesion-causative mechanisms. However, in this context, it should be noted that IND as well as the ω-3 fatty acid menhaden oil, were found to inhibit PGs production and also promotion of GGT-positive foci development by a semisynthetic CDML diet in rat liver initiated by N-nitrosodiethylamine (16) . It is plausible that the CDAA diet might have caused more severe perturbation of the AA cascade than with the semisynthetic CDML, requiring stronger COX inhibition. All the inhibitors used preferentially inhibit COX-1, although they also affect COX-2 at very high doses (35, 36) . Aspirin is known to irreversibly inhibit both COX-1 and -2 by acetylating serine 530 which causes steric blockage of the catalytic channel (37) (38) (39) . PIRO and IBU are both reversible competitive inhibitors for COX-1 and -2 (36, 38, 39) , but the present differences in their lesion-preventive potentials, in spite of a four-fold higher IC 50 (concentration required for 50% inhibition) value for COX-1 with PIRO than with IBU (36), could be partly ascribed to variation in their plasma half-lives, 8.3-13.3 h for PIRO (40, 41 ) and 1.7-2.8 h for IBU (42) , in male rats. However, the present lack of clear lesion-preventive effects of IND is surprising. IND, a noncovalent binding, reversible, competitive inhibitor, which causes time-dependent profound effects probably by salt bridging with Arg 120 in the catalytic channel for both COX-1 and -2 (36, 38, 39) , has a plasma half-life of 6.6-7.3 h in male rats (43, 44) , and 1/30-1/100 lower IC 50 value for COX-1 than IBU (35, 36) . It might partly be ascribed to that the doses of IND used in the present study were roughly 1/10 of those selected for IBU because of relatively strong side effects on the gastro-intestinal tract. Further, the induced COX-2 might have been involved since the inhibitors require higher doses for the inhibition of COX-2 (35, 36) . Taken together, the present results suggest that augmentation of the COX pathway due to a perturbed AA cascade might play key roles in the induction of pathological lesion by a CDAA diet.
We must, however, bear in mind the possibility that aspirin and PIRO might have influenced other pathways that were not affected by IND. In fact, aspirin but not IND has been reported to inhibit activation of NF-κB, a transcription factor that is involved in cytokine expression (45) . Further, it is reported that loss of COX inhibition in a metabolite of sulindac, is not associated with decrease in inhibitory potential against colon carcinogenesis (46) . Further studies on the levels of PGs, TXs and leukotriene (LT)s, COX activity and COX isozymes in the livers of rats given a CDAA diet, would therefore be warranted.
Evidence has accumulated that activation of nonparenchymal cells and the resultant release of cytokines, eicosanoids or reactive oxygen species, play important roles in the generation of hepatocyte injury and fibrosis (47, 48) . In fact, an involvement of TXA 2 , produced by activated Kupffer cells, in endotoxin-induced hepatocyte injury (49, 50) and its inhibition by aspirin in rats (49) but not by IND in mice (50), has been reported. TXA 2 and LTs also participate in CCl 4 -induced hepatocyte injury and fibrosis (48) . Transforming growth factor (TGF)-β or superoxide anions produced by activated Kupffer cells in CCl 4 -treated liver (47), or lipid peroxidation products including 4-hydroxynonenal formed in hepatocytes exposed to CCl 4 (51, 52) , can activate Ito (fat-storing) cells to produce extracellular matrix (53) . The COX and LOX pathways per se cause generation of reactive oxygen species, peroxides and superoxide anions, particularly in the presence of reducing cosubstrates, and conversely peroxides can trigger COX and LOX activity (54) . PGs are also involved in the activation of NADP(H) oxidase in neutrophils (55) . Reportedly, in rat livers given a CDAA or CDML diet, Ito cells are activated and transformed into myofibroblast-like cells (56) , with up-regulated expressions of TGF-β, TGF-α and hepatocyte growth factor genes (57) . TGF-β might also be derived from proliferating oval cells (58) which are a prominent histological feature of livers in rats given CDAA or CDML diet. Taken together, the present results thus suggest that products of the COX pathway, PGs, TXs or reactive oxygen species, in either parenchymal or nonparenchymal cells, might elicit a complicated web of interactions among eicosanoids, reactive oxygen species and cytokines, resulting in the liver lesions in the CDAA diet model. Present significant lowering effects of 8-OHdG by all the COX inhibitors, although partly being ascribed to scavenging potentials of hydroxyl radicals, particularly for aspirin and IBU (59, 60) , might suggest important roles of the COX pathway in generating reactive oxygen species.
Furthermore, the present inhibition of the preneoplastic and neoplastic lesions by the COX inhibitors might partly be ascribed to their blockade of growth promotion by growth factors since PGE 2 and/or PGF 2α production in hepatocytes appears to be involved in the mitogenic signal cascade by hepatocyte growth factor (15, 61) , epidermal growth factor (61) and TGF-α (62). Moreover, since COX-2 may be induced upon activation of nonparenchymal or parenchymal cells (24, 63) , while only COX-1 is expressed in normal rat livers (64) , further studies using specific COX-2 inhibitors would be informative.
It should further be noted that PGE 2 , in spite of being produced by activated Kupffer cells, can down-regulate the production of various cytokines (48) and up-regulate collagenase gene expression (65) in Kupffer cells. In fact, exogenous administration of PGE 2 and its derivatives can prevent liver injury and fibrosis in various rat models including one featuring application of a CDML diet (48) .
Nevertheless, from the present results we can conclude that PIRO, like aspirin, can prevent endogenous hepatocarcinogenesis as well as fibrosis and oxidative DNA damage caused by a CDAA diet in rats.
